September 19, 2017 – 10 am ET
Join Kathryn Starzyk, Senior Director of Research and Epidemiology, at OM1, as she discusses the evolving role of big data and cognitive computing in generating real-world evidence for rheumatology and related immunologic disorders.
This session will explore how advanced technologies and approaches can be applied to support real-world evidence, value and commercialization strategies.
- New real-world evidence methodologies and their application in rheumatologic disease research
- Using linked data to understand the patient journey, treatment choices, provider and payer factors, and outcomes
- Applying advanced analytics to identify clinical subset response to different treatments and predict risks
- Understanding the opportunities with using big data to demonstrate comparative and cost effectiveness